Symptomatic burden as an endpoint to evaluate interventions in patients with atrial fibrillation
- 7 March 2005
- journal article
- Published by Elsevier BV in Heart Rhythm
- Vol. 2 (5), 544-549
- https://doi.org/10.1016/j.hrthm.2005.01.028
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL-65962)
This publication has 45 references indexed in Scilit:
- Genome-Wide Linkage Scan Identifies a Novel Genetic Locus on Chromosome 5p13 for Neonatal Atrial Fibrillation Associated With Sudden Death and Variable CardiomyopathyCirculation, 2004
- Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in OffspringJAMA, 2004
- Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyCirculation, 2004
- Inflammation as a Risk Factor for Atrial FibrillationCirculation, 2003
- Familial atrial fibrillation is a genetically heterogeneous disorderJournal of the American College of Cardiology, 2003
- Locus for Atrial Fibrillation Maps to Chromosome 6q14–16Circulation, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trialThe Lancet, 2000
- Identification of a Genetic Locus for Familial Atrial FibrillationNew England Journal of Medicine, 1997